NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 882.50
+4.75 (0.54%)
At close: Aug 21, 2026
NATCO Pharma Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 34,846 | 40,783 | 44,319 | 40,020 | 27,085 | 19,462 |
Revenue Growth | -20.73% | -7.98% | 10.74% | 47.76% | 39.17% | -5.34% |
Gross Profit Gross Profit Growth | 28,796 | 33,878 | 37,045 | 32,533 | 20,541 | 13,617 |
Operating Income Operating Income Growth | 8,559 | 12,299 | 19,662 | 15,706 | 8,098 | 1,234 |
Net Income Net Income Growth | 11,443 | 14,185 | 18,854 | 13,883 | 7,153 | 1,700 |
Earnings Per Share EPS Growth | 63.89 | 79.20 | 105.26 | 77.34 | 39.18 | 9.32 |
EPS Growth | -32.59% | -24.76% | 36.10% | 97.40% | 320.39% | -61.42% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Pharmaceuticals Pharmaceuticals Growth | 33,403 | 39,401 | 43,689 | 38,905 | 26,662 | 19,399 |
Agro Chemicals Agro Chemicals Growth | 1,443 | 1,382 | 606 | 1,083 | 409 | 49 |
Total Total Growth | 34,846 | 40,783 | 44,295 | 39,988 | 27,071 | 19,448 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 21,291 | 21,291 | 24,899 | 13,912 | 7,931 | 7,599 |
Total Debt Total Debt Growth | 7,139 | 7,139 | 2,794 | 3,861 | 1,761 | 4,320 |
Net Cash (Debt) Net Cash Growth | 14,152 | 14,152 | 22,105 | 10,051 | 6,170 | 3,279 |
Net Cash Growth | -36.18% | -35.98% | 119.93% | 62.90% | 88.17% | -38.57% |
Net Cash Per Share Net Cash Per Share Growth | 79.02 | 79.02 | 123.42 | 56.00 | 33.80 | 17.98 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | 17,683 | 16,968 | 12,116 | 8,491 | 465 |
Capital Expenditures CapEx Growth | - | -3,883 | -4,011 | -3,394 | -1,463 | -2,328 |
Free Cash Flow Free Cash Flow Growth | - | 13,800 | 12,957 | 8,722 | 7,028 | -1,863 |
Free Cash Flow Growth | - | 6.51% | 48.55% | 24.10% | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 82.64% | 83.07% | 83.59% | 81.29% | 75.84% | 69.97% |
Operating Margin | 24.56% | 30.16% | 44.37% | 39.25% | 29.90% | 6.34% |
Pretax Margin | 35.45% | 37.70% | 51.70% | 41.82% | 31.82% | 10.39% |
Profit Margin | 32.84% | 34.78% | 42.54% | 34.69% | 26.41% | 8.73% |
FCF Margin | - | 33.84% | 29.24% | 21.79% | 25.95% | -9.57% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 4.500 | 5.000 | 6.000 | 9.500 | 5.500 | 4.500 |
Dividend Per Share Growth | -10.00% | -16.67% | -36.84% | 72.73% | 22.22% | -14.29% |
Dividend Yield | 0.51% | 0.51% | 0.76% | 1.01% | 1.00% | 0.61% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 22, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.81 | 12.30 | 7.59 | 12.28 | 14.37 | 81.18 |
P/FCF Ratio | 11.45 | 12.64 | 11.04 | 19.55 | 14.63 | - |
PS Ratio | 4.54 | 4.28 | 3.23 | 4.26 | 3.80 | 7.09 |